TCR2 Therapeutics Inc (NASDAQ:TCRR)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TCRR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TCRR

  • Market Cap$1.139bn
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS87808K1060

Company Profile

TCR2 Therapeutics Inc is a biotechnology company. It is engaged in developing a new generation of T cell therapies for patients suffering from cancer. Its TCR Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor TCR signaling complex, which is effective in patients with solid tumors.

Latest TCRR news

Currently there for this company. Visit our news hub for other news .